Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Mark Gelfand - aVenture Research

Mark Gelfand

AddedMar 31, 2024

UpdatedOct 15, 2026

Mark Gelfand

Mark Gelfand

Co-Founder, Soffio Medical

Mark Gelfand's Career

Soffio Medical

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Series A$3MBoston, MA, US

Co-Founder

Axon Therapies

Series A$3.3MNew York City, NY, US

Co-Founder

Coridea

$3.9MNew York City, NY, US

Co-Founder

CorVent Medical

Seed$4.5MFargo, ND, US

Board Member· Board

Cibiem

$13MLos Altos, CA, US

Co-Founder

People Similar to Mark Gelfand

Raymond W. CohenBoard Member · Axonics

Tyler MeltonFounder · Corveus Medical

Ishan KamatFounder · Corveus Medical

Raphael WisniewskiBoard Member · Bioventrix

Leadership at Soffio Medical

Aaron SandoskiBoard Member

Similar to Soffio Medical

Invent MedicalCarlsbad, CA, USMedical Devicesest. 2014Invent MedicalCarlsbad, CA, US · est. 2014

Invent Respiratory: Developing advanced respiratory care devices for patient recovery and rehabilitation.

Seed · $258.1k6

Aero TherapeuticsSan Diego, CA, USMedical Devicesest. 2019Aero TherapeuticsSan Diego, CA, US · est. 2019

Aero Therapeutics: Developing respiratory aid devices for low-resource settings.

Portela Soni MedicalBoston, MA, USMedical Devicesest. 2014Portela Soni MedicalBoston, MA, US · est. 2014

Portela Soni Medical: Innovating patient care with our problem-solving catheter device.

Osia MedicalSandy, UT, USMedical Softwareest. 2013Osia MedicalSandy, UT, US · est. 2013

OSIA Medical: Empowering asthma patients and physicians through innovative software solutions.

Seed · $525.4k30

Similar to Coridea

Specialty Renal ProductsSouth Orange, NJ, USMedical Devicesest. 2018Specialty Renal ProductsSouth Orange, NJ, US · est. 2018

Specialty Renal Products, Inc.: Developing innovative medical devices for renal disease patients.

Series A · $3M30

ViacorWilmington, MA, USMedical Devicesest. 1999ViacorWilmington, MA, US · est. 1999

Viacor: Innovating catheter-based solutions for heart valve diseases and CHF.

Series C · $34M30

CorinnovaHouston, TX, USMedical Devicesest. 2004CorinnovaHouston, TX, US · est. 2004

Corinnova: Pioneering healthcare solutions for congestive heart failure treatment.

Angel · $7.3M749

InnovaCorSaint Paul, MN, USInventory Management, Medical Devicesest. 2010InnovaCorSaint Paul, MN, US · est. 2010

InnovaCor: Streamlining healthcare with medical device distribution and inventory solutions since 2010.

Leadership at Cibiem

Neil ExterBoard Member

Paul LavioletteBoard Member

Hank KuchemanBoard Member

Similar to Cibiem

Niche BiomedicalLos Angeles, CA, USMedical Devicesest. 2016Niche BiomedicalLos Angeles, CA, US · est. 2016

Niche Biomedical: Innovating neuromodulation devices for enhanced human health.

Leadership at Axon Therapies

Zoar EngelmanCo-Founder

Chad HoskinsCEO

Howard LevinCo-Founder

Similar to Axon Therapies

Axonis TherapeuticsCambridge, MA, USDrug Discovery, Therapeuticsest. 2008Axonis TherapeuticsCambridge, MA, US · est. 2008

AXONIS Therapeutics pioneers breakthrough therapies for incurable neurological disorders.

Series A · $14.5M38

AxonicsIrvine, CA, USMedical Devicesest. 2012AxonicsIrvine, CA, US · est. 2012

California-based Axonics, Inc. designs and markets innovative, minimally invasive medical solutions globally.

AxoftCambridge, MA, USMedical Devicesest. 2021AxoftCambridge, MA, US · est. 2021

Axoft develops bioinspired, scalable implants for enhanced nervous system communication and improved health outcomes.

CardionomicNew Brighton, MN, USMedical Devicesest. 2011CardionomicNew Brighton, MN, US · est. 2011

Cardionomic provides transformative treatments for ADHF by neuromodulating the cardiac plexus to improve cardiac output and renal blood flow.

Series B · $49.8M28

Leadership at CorVent Medical

Richard S. WalshCEO

Similar to CorVent Medical

Ventis MedicalPrinceton, NJ, USMedical Devicesest. 2020Ventis MedicalPrinceton, NJ, US · est. 2020

Ventis Medical: Developing and supplying affordable, user-friendly medical ventilators.

Series A · $4.1M7

AccuBreathSandy, UT, USVentilatorsest. 2017AccuBreathSandy, UT, US · est. 2017

Leading medical device company specializing in affordable, high-end, ultraportable ventilators.

Angel · $1.3M6

Ventec Life SystemsBothell, WA, USMedical Devicesest. 2013Ventec Life SystemsBothell, WA, US · est. 2013

Ventec Life Systems: A leading American medical device company based in Washington.

Series E · $59.1M75

Emergent RespiratoryCarlsbad, CA, USMedical Devicesest. 2000Emergent RespiratoryCarlsbad, CA, US · est. 2000

Emergent Respiratory manufactures innovative medical devices for non-invasive ventilation therapy and dyspnea treatment.

Series A · $5.3M4

NBI DevelopmentSan Francisco, CA, USMedical Devicesest. 1995

NBI DevelopmentSan Francisco, CA, US · est. 1995

NBI Development: Innovating neuromodulation therapies via implantable medical devices.

Seed · $5.5M5

SeaStar MedicalAnn Arbor, MI, USMedical Devicesest. 2007SeaStar MedicalAnn Arbor, MI, US · est. 2007

CytoPherx Inc. offers proprietary medical devices for treating inflammation-based diseases.

Public · $50.2M5

Sympara MedicalSan Francisco, CA, USHypertension Therapiesest. 2012Sympara MedicalSan Francisco, CA, US · est. 2012

Sympara Medical: Pioneering novel hypertension therapies since 2012, based in San Francisco.

Series A · $12.8M5